[go: up one dir, main page]

GB9802599D0 - Medical use - Google Patents

Medical use

Info

Publication number
GB9802599D0
GB9802599D0 GBGB9802599.2A GB9802599A GB9802599D0 GB 9802599 D0 GB9802599 D0 GB 9802599D0 GB 9802599 A GB9802599 A GB 9802599A GB 9802599 D0 GB9802599 D0 GB 9802599D0
Authority
GB
United Kingdom
Prior art keywords
medical use
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GBGB9802599.2A
Other versions
GB2330307A (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Glaxo Group Ltd
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Priority to GB9802599A priority Critical patent/GB2330307A/en
Publication of GB9802599D0 publication Critical patent/GB9802599D0/en
Publication of GB2330307A publication Critical patent/GB2330307A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
GB9802599A 1998-02-07 1998-02-07 EP4 Receptor antagonists as bone resorption inhibitors Withdrawn GB2330307A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB9802599A GB2330307A (en) 1998-02-07 1998-02-07 EP4 Receptor antagonists as bone resorption inhibitors

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9802599A GB2330307A (en) 1998-02-07 1998-02-07 EP4 Receptor antagonists as bone resorption inhibitors

Publications (2)

Publication Number Publication Date
GB9802599D0 true GB9802599D0 (en) 1998-04-01
GB2330307A GB2330307A (en) 1999-04-21

Family

ID=10826610

Family Applications (1)

Application Number Title Priority Date Filing Date
GB9802599A Withdrawn GB2330307A (en) 1998-02-07 1998-02-07 EP4 Receptor antagonists as bone resorption inhibitors

Country Status (1)

Country Link
GB (1) GB2330307A (en)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU766163B2 (en) 1999-03-05 2003-10-09 Duke University C16 unsaturated fp-selective prostaglandins analogs
US6894175B1 (en) 1999-08-04 2005-05-17 The Procter & Gamble Company 2-Decarboxy-2-phosphinico prostaglandin derivatives and methods for their preparation and use
JP2003506404A (en) * 1999-08-10 2003-02-18 グラクソ グループ リミテッド Use of EP4 receptor ligands in therapy, especially in the treatment of neuropathic pain and colon cancer
TWI247606B (en) * 1999-11-24 2006-01-21 Ono Pharmaceutical Co Treating agent for osteopenic diseases
AP2002002555A0 (en) * 1999-12-22 2002-06-30 Pfizer Prod Inc EP4 Receptor selective agonists in the treatment of osteoporosis.
US20020172693A1 (en) 2000-03-31 2002-11-21 Delong Michell Anthony Compositions and methods for treating hair loss using non-naturally occurring prostaglandins
US20020037914A1 (en) 2000-03-31 2002-03-28 Delong Mitchell Anthony Compositions and methods for treating hair loss using C16-C20 aromatic tetrahydro prostaglandins
US20020013294A1 (en) 2000-03-31 2002-01-31 Delong Mitchell Anthony Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives
HN2001000224A (en) 2000-10-19 2002-06-13 Pfizer IMIDAZOL COMPOUNDS CONDENSED WITH ARILO OR HETEROARILO AS ANTI - INFLAMMATORY AND ANALGESIC AGENTS.
PL367740A1 (en) 2001-07-23 2005-03-07 Ono Pharmaceutical Co, Ltd. Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient
EP1450813B1 (en) * 2001-10-31 2007-08-29 Medical Research Council Antagonists of prostaglandin receptors ep2 and/or ep4 for the treatment of menorrhagia
EP2217242A1 (en) * 2007-11-15 2010-08-18 Eisai R&D Management Co., Ltd. Methods of use
US8623918B2 (en) 2008-10-29 2014-01-07 Novaer Holdings, Inc. Amino acid salts of prostaglandins
US8722739B2 (en) 2008-10-29 2014-05-13 Novaer Holdings, Inc. Amino acid salts of prostaglandins
EP2555773A1 (en) * 2010-04-08 2013-02-13 Boehringer Ingelheim International GmbH Combinations of medicaments, containing pde4 inhibitors and ep4 receptor antagonists

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL62734A (en) * 1980-04-30 1985-10-31 Glaxo Group Ltd Aminocyclopentane alkenoic acids and esters,their preparation and pharmaceutical formulations

Also Published As

Publication number Publication date
GB2330307A (en) 1999-04-21

Similar Documents

Publication Publication Date Title
GB9915414D0 (en) Medical use
GB2341960B (en) Medical calculator
GB9818914D0 (en) Use
AU142196S (en) Tissue
GB9802599D0 (en) Medical use
GB9907965D0 (en) Medical use
AU142195S (en) Tissue
GB9700875D0 (en) Medical devices
GB9925379D0 (en) Medical use
AU140956S (en) Tissue
GB9816897D0 (en) Therapeutic use
GB9810920D0 (en) Therapeutic use
GB9812662D0 (en) Therapeutic use
GB9807503D0 (en) Use
GB9828004D0 (en) Use
EP1140120A4 (en) Human brainiac-5
AU142197S (en) Tissue
GB9827865D0 (en) Medicament
GB9922825D0 (en) Medical use
GB9811624D0 (en) Therapeutic use
GB9821179D0 (en) Therapeutic use
GB9812664D0 (en) Therapeutic use
TW387258U (en) Medical air-sucker
GB9601042D0 (en) Medical use
GB9812615D0 (en) Therapeutic use

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)